Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-06-07 Purchase |
2023-06-09 3:28 pm |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
130,000 | $0.04 | $5,200 | 10,990,277 (Indirect Direct) |
View |
2023-01-27 Purchase |
2023-02-02 3:04 pm |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
20,000 | $0.14 | $2,800 | 10,418,277 (Indirect Direct) |
View |
2023-01-27 Purchase |
2023-02-02 12:47 pm |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
20,000 | $0.14 | $2,800 | 10,418,277 (Indirect Direct) |
View |
2022-07-21 Sale |
2022-07-25 11:24 am |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
5,000 | $0.26 | $1,300 | 10,132,277 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-06-30 Other |
2024-07-02 08:51 am |
N/A N/A |
Nascent Biotech Inc. | NBIO | Karas Douglas John Director |
50,000 | $0.1 | 1,871,552 (Direct) |
View |
2024-06-30 Other |
2024-07-02 08:51 am |
N/A N/A |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
96,000 | $0.09 | 10,101,477 (Direct) |
View |
2024-06-30 Other |
2024-07-02 08:50 am |
N/A N/A |
Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner |
192,000 | $0.09 | 23,318,007 (Direct) |
View |
2024-03-31 Other |
2024-04-10 1:07 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
112,500 | $0.1845 | 12,021,977 (Direct) |
View |
2024-03-31 Other |
2024-04-10 1:06 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner |
225,000 | $0.1845 | 23,159,007 (Direct) |
View |
2024-03-31 Other |
2024-04-10 1:06 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Karas Douglas John Director |
27,100 | $0.1845 | 1,798,652 (Direct) |
View |
2023-12-29 Other |
2024-02-27 1:46 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner |
239,300 | $0.17 | 22,948,307 (Direct) |
View |
2023-12-29 Other |
2024-02-27 1:46 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
119,650 | $0.17 | 11,916,627 (Direct) |
View |
2023-12-29 Other |
2024-02-27 1:45 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Karas Douglas John Director |
28,935 | $0.18 | 1,773,387 (Direct) |
View |
2023-09-29 Other |
2023-11-09 2:22 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Karas Douglas John Director |
39,750 | $0.125 | 1,755,267 (Direct) |
View |
2023-09-29 Other |
2023-11-09 2:22 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
1,386,300 | $0.125 | 13,063,627 (Direct) |
View |
2023-09-29 Other |
2023-11-09 2:21 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner |
2,772,600 | $0.125 | 25,242,307 (Direct) |
View |
2023-06-29 Gift |
2023-07-14 08:42 am |
N/A N/A |
Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner |
960,000 | $0.05 | 19,697,107 (Direct) |
View |
2023-06-29 Gift |
2023-07-13 11:26 am |
N/A N/A |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
700,000 | $0.049 | 10,291,027 (Direct) |
View |
2023-03-31 Other |
2023-06-09 3:28 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Karas Douglas John Director |
89,285 | $0.06 | 1,665,052 (Direct) |
View |
2023-03-31 Other |
2023-06-09 3:28 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
581,000 | $0.06 | 10,990,277 (Direct) |
View |
2023-03-31 Other |
2023-06-09 3:27 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner |
1,167,000 | $0.06 | 20,400,607 (Direct) |
View |
2023-02-09 Gift |
2023-02-14 06:22 am |
N/A N/A |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
700,000 | $0.12 | 9,798,277 (Direct) |
View |
2022-12-30 Other |
2023-01-03 3:09 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Karas Douglas John Director |
25,000 | $0.2 | 1,511,482 (Direct) |
View |
2022-12-30 Option Award |
2023-01-03 3:08 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
231,000 | $0.2 | 10,398,277 (Direct) |
View |
2022-12-30 Other |
2023-01-03 3:08 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner |
462,000 | $0.2 | 18,533,607 (Direct) |
View |
2022-04-14 Gift |
2022-04-19 09:58 am |
N/A N/A |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
700,000 | $0.08 | 8,283,077 (Direct) |
View |
2022-03-09 Other |
2022-04-04 4:01 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Karas Douglas John Director |
300,000 | $0.05 | 1,727,853 (Direct) |
View |
2022-03-31 Other |
2022-04-04 4:01 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
215,000 | $0.056 | 12,298,077 (Direct) |
View |
2022-03-09 Other |
2022-04-04 4:01 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
1,100,000 | $0.05 | 12,298,077 (Direct) |
View |
2022-03-31 Other |
2022-04-04 4:01 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner |
430,000 | $0.056 | 18,881,131 (Direct) |
View |
2022-03-09 Other |
2022-04-04 4:01 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner |
1,000,000 | $0.05 | 18,881,131 (Direct) |
View |
2021-06-30 Other |
2022-02-08 5:07 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
173,700 | $0.105 | 10,715,477 (Direct) |
View |
2021-04-15 Gift |
2022-02-08 5:07 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
3,400,000 | $0.05 | 10,715,477 (Direct) |
View |
2021-06-30 Other |
2022-02-08 5:06 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner |
347,400 | $0.105 | 16,368,531 (Direct) |
View |
2021-06-30 Other |
2021-08-20 09:50 am |
N/A N/A |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
173,700 | $0.061 | 18,383,554 (Direct) |
View |
2021-06-30 Other |
2021-08-20 09:50 am |
N/A N/A |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
700,000 | $0.105 | 18,383,554 (Indirect) |
View |
2021-06-30 Other |
2021-08-20 09:49 am |
N/A N/A |
Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner |
347,400 | $0.105 | 16,368,531 (Direct) |
View |
2021-06-30 Other |
2021-08-20 09:48 am |
N/A N/A |
Nascent Biotech Inc. | NBIO | Karas Douglas John Director |
83,334 | $0.105 | 1,518,198 (Direct) |
View |
2021-04-09 Other |
2021-08-20 09:48 am |
N/A N/A |
Nascent Biotech Inc. | NBIO | Karas Douglas John Director |
307,010 | $0.076 | 1,518,198 (Direct) |
View |
2021-03-31 Other |
2021-04-06 12:32 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Karas Douglas John Director |
83,334 | $0.07 | 856,558 (Direct) |
View |
2021-03-26 Other |
2021-04-06 12:31 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner |
1,250,000 | $0.06 | 18,543,731 (Direct) |
View |
2021-03-31 Other |
2021-04-06 12:31 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner |
1,620,000 | $0.061 | 18,543,731 (Direct) |
View |
2021-03-26 Other |
2021-04-06 12:28 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
1,000,000 | $0.06 | 12,178,077 (Direct) |
View |
2021-03-31 Other |
2021-04-06 12:28 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
810,000 | $0.061 | 12,178,077 (Direct) |
View |
2020-09-30 Other |
2021-01-11 5:00 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Karas Douglas John Director |
71,430 | $0.07 | 1,219,780 (Direct) |
View |
2020-11-20 Other |
2021-01-11 5:00 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Karas Douglas John Director |
350,000 | $0.05 | 1,219,780 (Direct) |
View |
2020-12-31 Other |
2021-01-11 5:00 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Karas Douglas John Director |
108,460 | $0.046 | 1,219,780 (Direct) |
View |
2020-09-30 Other |
2021-01-11 5:00 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
127,970 | $0.07 | 10,128,047 (Direct) |
View |
2020-12-31 Other |
2021-01-11 5:00 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO |
1,442,000 | $0.0461 | 10,128,047 (Direct) |
View |
2020-12-31 Other |
2021-01-11 5:00 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner |
2,884,000 | $0.0461 | 15,906,446 (Direct) |
View |
2020-09-30 Other |
2021-01-11 5:00 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner |
218,715 | $0.1 | 15,906,446 (Direct) |
View |
2020-06-24 Other |
2020-07-02 1:36 pm |
N/A N/A |
Nascent Biotech Inc. | NBIO | Price Brandon Senior VP Business Development 10% Owner |
3,355,830 | $0.1 | 10,358,158 (Direct) |
View |